Risk Factor Analysis for Bevacizumab-induced Severe Hypertension in Advanced Breast Cancer Treatment

Pre-existing hypertension is a risk factor for BV-induced severe hypertension in patients with breast cancer.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2025-12-30
DOI
https://doi.org/10.21873/anticanres.17952
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk Factor Analysis for Bevacizumab-induced Severe Hypertension in Advanced Breast Cancer Treatment

Hiroaki Sakurada, YOSHIHIKO SUGINO, MISAKO BABA, YOSHITAKA SAITO
Anticancer Research
Chemotherapy-induced cardiotoxicity and mitigation
article

Risk Factor Analysis for Bevacizumab-induced Severe Hypertension in Advanced Breast Cancer Treatment

Hiroaki Sakurada, YOSHIHIKO SUGINO, MISAKO BABA, YOSHITAKA SAITO
article en

Abstract

Pre-existing hypertension is a risk factor for BV-induced severe hypertension in patients with breast cancer.

Anticancer ResearchVol. 46(1)
Ichinomiya Municipal City Hospital (JP)
Good health and well-being
Openalex Percentile: Top 30%
Chemotherapy-induced cardiotoxicity and mitigation
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Risk Factor Analysis for Bevacizumab-induced Severe Hypertension in Advanced Breast Cancer Treatment — Hiroaki Sakurada, YOSHIHIKO SUGINO, et al. · Anticancer Research (2025) | TGRS Research Map | TGRS